首页 › 基金 › ABRAMS CAPITAL MANAGEMENT, L.P. › NUVB

ABRAMS CAPITAL MANAGEMENT, L.P. 对 NUVB 的持仓历史

NUVATION BIO INC · 医疗保健

ABRAMS CAPITAL MANAGEMENT, L.P. 在 Q3 2026 的 13F 申报中披露持有 NUVB(NUVATION BIO INC)1,270,504 股,市值约 US$7.1M,约占其申报组合的 0.15%,在其申报持仓中市值排名第 11 位。 ABRAMS CAPITAL MANAGEMENT, L.P. 最近 13 个申报季度中有 13 个季度披露了 NUVB 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)1.27M 股
申报持仓市值$7.11M
组合权重0.15%
首次申报Q3 2023
最近变动持有
更新于2026-11-14

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

ABRAMS CAPITAL MANAGEMENT, L.P. 对 NUVB 的持仓演变

ABRAMS CAPITAL MANAGEMENT, L.P. 于 Q3 2023 首次披露 NUVB 持仓:3,811,513 股(约 US$5.1M)。 该持仓在 Q4 2025 达到峰值 3,811,513 股,市值约 US$34.2M。 在 13 次申报中,ABRAMS CAPITAL MANAGEMENT, L.P. 0 次增持、1 次减持、11 次保持不变。 最近一期申报(Q3 2026)显示持股 1,270,504 股、市值约 US$7.1M。 持仓曾出现大幅变动:Q1 2026 减持约 67% (随后一个季度股价上涨 32%)。

逐季持仓明细

季度股数金额变化
Q3 2023 3.81M $5.11M 新进
Q4 2023 3.81M $5.76M 持有
Q1 2024 3.81M $13.87M 持有
Q2 2024 3.81M $11.13M 持有
Q3 2024 3.81M $8.73M 持有
Q4 2024 3.81M $10.14M 持有
Q1 2025 3.81M $6.71M 持有
Q2 2025 3.81M $7.43M 持有
Q3 2025 3.81M $14.10M 持有
Q4 2025 3.81M $34.15M 持有
Q1 2026 1.27M $5.45M 减持
Q2 2026 1.27M $7.22M 持有
Q3 2026 1.27M $7.11M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 NUVB 与 13F 数据

NUVB(NUVATION BIO INC)属于医疗保健行业。我们追踪的基金中还有 54 只申报持有 NUVB,申报仓位最大的包括:Decheng Capital LLC (US$145.3M), Context Capital Management, LLC (US$53.1M), Omega Fund Management, LLC (US$45.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 NUVB 的基金

查看 NUVB 的全部基金持有人 →

常见问题

How long has ABRAMS CAPITAL MANAGEMENT, L.P. held NUVB?

ABRAMS CAPITAL MANAGEMENT, L.P. has disclosed NUVB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ABRAMS CAPITAL MANAGEMENT, L.P.'s current position in NUVB?

As of Q3 2026, ABRAMS CAPITAL MANAGEMENT, L.P. holds 1.27M shares of NUVB (NUVATION BIO INC), valued at $7.11M, representing 0.15% of its reported portfolio and ranking #11.

Has ABRAMS CAPITAL MANAGEMENT, L.P. been buying or selling NUVB?

In the latest 13F filing (Q3 2026), ABRAMS CAPITAL MANAGEMENT, L.P. held unchanged its position in NUVB. The position peaked in Q4 2025 at 3.81M shares.

Which other funds hold NUVB?

Other major institutional holders of NUVB include Decheng Capital LLC, Context Capital Management, LLC, Omega Fund Management, LLC, among 54 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.